Semler Scientific, Inc.
SMLR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | 0.33 | -0.92 | 1.77 |
| FCF Yield | 6.24% | 6.88% | 6.89% | 2.47% |
| EV / EBITDA | 17.74 | 10.22 | 11.20 | 28.89 |
| Quality | ||||
| ROIC | 7.65% | 26.42% | 24.91% | 37.52% |
| Gross Margin | 91.55% | 89.76% | 92.50% | 88.45% |
| Cash Conversion Ratio | 0.60 | 0.87 | 1.22 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.23% | 8.74% | 13.66% | 17.41% |
| Free Cash Flow Growth | 18.81% | 33.97% | 0.47% | 6.10% |
| Safety | ||||
| Net Debt / EBITDA | -0.41 | -2.42 | -1.28 | -1.84 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 13.29 | 15.69 | 9.07 | 11.13 |
| Cash Conversion Cycle | 45.11 | 35.04 | -6.41 | 31.29 |